| CAS ID: | 148553-50-8 |
| Molecular Formula: | C8H17NO2 |
| Molecular Weight: | 159.2 g/mol |
| Monoisotopic Mass: | 159.1259 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | REWISCA | PD-144723 | LECAENT | LYRICA | AXALID | PREGABALIN | LYRICA CR | ALZAIN | CI-1008 |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT01271660 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Completed |
| First Received | January 7, 2011 | Last Verified | April 24, 2018 |
| Sponsor | Seoul National University Boramae Hospital | ||
Trial Record 2
| ClinicalTrial ID | NCT00310765 | Disease | Scar |
| Phase | Phase 4 | Status | Terminated |
| First Received | April 4, 2006 | Last Verified | September 5, 2012 |
| Sponsor | Henry Ford Health System | ||
| PubChem: | 5486971 |
| ChEMBL: | CHEMBL1059 |